No Detail Found!

Spectrum of microbial agents responsible for bloodstream infection and their sensitivity pattern in pediatric patients having chemotherapy induced neutropenia

Author(s)
Ghulam Jelani Departments of Pediatric Oncology and Pathology, Pakistan Institute of Medical Sciences,Islamabad,Pakistan
Nuzhat Yasmeen Departments of Pediatric Oncology and Pathology, Pakistan Institute of Medical Sciences,Islamabad,Pakistan
Nighat Haider Departments of Pediatric Oncology and Pathology, Pakistan Institute of Medical Sciences,Islamabad,Pakistan
Bilal Ali Anjum Departments of Pediatric Oncology and Pathology, Pakistan Institute of Medical Sciences,Islamabad,Pakistan
Jai Krishin Departments of Pediatric Oncology and Pathology, Pakistan Institute of Medical Sciences,Islamabad,Pakistan
Maqbool Hussain Departments of Pediatric Oncology and Pathology, Pakistan Institute of Medical Sciences,Islamabad,Pakistan
Abstract
Objective: To identify the microbial agents responsible for bloodstream infection and their sensitivity pattern in pediatric patients having chemotherapy induced neutropenia. Methodology: It was an observational, crosssectional study carried out from April 2020 to November 2020 at department of pediatric oncology& pathology, Pakistan Institute of Medical Sciences, Islamabad. A total of 223 patients of both gender between 3 to 12 years of age with chemotherapy induced febrile neutropenia were enrolled. The blood samples showing growth of bacterial agents on culture medium were identified and antibiograms of these samples were recorded. Results: Fifty eight percent patients were culture positive. Most frequent pathogen identified was coagulase negative S. aureus (40%) followed by Pseudomonas (37%) and E. coli. (11%). Sensitivity analysis revealed that 58% of S. aureus were sensitive to chloramphenicol, doxycycline, linezolid and vancomycin and 67% of Pseudomonas spp. showed sensitivity to imipenem, levofloxacin, amikacin and piperacillin + tazobactam. All identified E. coli were sensitive to amikacin, piperacillin + tazobactam, imipenem and cefoperazone. All identified Acinobacter were sensitive to only imipenem. Conclusion: Frequency of febrile neutropenia is highest in younger age group and gram positive organisms are the commonest found on culture followed by gram negative pathogens and Fungai.
Publication Details
Page(s) 173-178
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 48, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
Febrile neutropenia, Acute lymphoblastic leukemia, chemotherapy induced neutropenia.
References
Stern A,Carrara E,Bitterman R,Yahav D,Leibovici L,Paul M. .2019 .Published 2019 Jan 3. Cochrane Database Syst Rev, 1(1) : CD012184.
Punnapuzha S,Edemobi PK,Elmoheen A. Febrile,Neutropenia A. Febrile,Available A. Febrile . .Treasure Island (FL): StatPearls Publishing; 2020 Jan-. [Updated 2020 Mar, 30 : .
McMullan BJ,Haeusler GM,Hall L,Cooley L,Stewardson AJ,Blyth CC .2020 .Aminoglycoside use in paediatric febrile neutropenia - Outcomes from a nationwide prospective cohort study. PLoS One, 15(9) : e0238787.
Agyeman P,Kontny U,Nadal D U .2014 .A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study. Pediatr Infect Dis J, 33 : e219.
Kara SS,Tezer H,Polat M,Yayla BCC,Demirdağ TB,Okur A .2019 .Risk factors for bacteremia in children with febrile neutropenia. Turk J Med Sci, 49 : 1198-205.
Hakim H,Flynn PM,Knapp KM .2009 .Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol, 31 : 623-9.
Castagnola E,Fontana V,Caviglia I. .2007 .A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis, 45 : 1296-1304.
Torres JP,Labraña Y,Ibañez C .2012 .Frequency and clinical outcome of respiratory viral infections and mixed viralbacterial infections in children with cancer, fever and neutropenia. Pediatr Infect Dis J, 31 : 889-93.
Lindblom A,Bhadri V,Söderhäll S. .2010 .Respiratory viruses, a common microbiological finding in neutropenic children with fever. J Clin Virol, 47 : 234-7.
Lakshmaiah KC,Malabagi AS,Shetty R,Sinha M,Jayashree RS .2015 .Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients. J Lab Physicians, 7 : 116-20.
Lee M,Yee J,Kim JY,Kim JY,An SH,Lee KE . .Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim. Asia Pac J Clin Oncol 2019 Apr, 10 : .
Saleem L,Zahid NA .2017 .. Is Serum Albumin an Independent Predictor of Post Chemotheray Febrile Neutropenia? Pak Armed Forces Med J, 67 : 768-74.
Jagarlamudi R,Kumar L,Kochupillai V,Kapil A,Banerjee U,Thulkar S. .2000 .Infections in acute leukemia: An analysis of 240 febrile episodes. Med Oncol, 17 : 111-6.
Mahmud S,Ghafoor T,Badsha S,Gul M S. .2004 .Bacterial infections in Pediatric patients with chemotherapy induced neutropenia. J Pak Med Assoc, 54 : 237-43.
Butt T,Afzal RK,Ahmad RN,Salman M,Mahmood A,Anwar M. .2004 .Bloodstream infections in Febrile Neutropenic Patients: Bacterial Spectrum and Antimicrobial Susceptibility pattern. J Ayub Med Coll Abottabad, 16 : 18-22.
Babu KG,Lokanatha D,Lakshmaiah KC,Babu MCS,Jacob LA,Bhat GR .2016 .Bloodstream infections in febrile neutropenic patients at a tertiary cancer institute in South India: A timeline of clinical and microbial trends through the years. Ind J Med Paed Onco, 37 : 174-182.
Mandal PK,Maji SK,Dolai TK,De R,Dutta S,Saha S .2015 .Micro-organisms Associated with Febrile Neutropenia in Patients with Haematological Malignancies in a Tertiary Care Hospital in Eastern India. Indian J Hematol Blood Transfus, 31 : 46-50.
Jamal A,Fatima N,Shaikh S,Kaleem B,Rizvi QA,Zaidi U .2019 .Clinical and Microbiological Profile of Pathogens in Febrile Neutropenia in Hematological Malignancies: A Single Center Prospective Analysis. Indian J Microbiol, 59 : 188-192.
Lehrnbecher T,Varwig D,Kaiser J .2004 .Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia, 18 : 72-7.
Vicente M,Al-Nahedh M,Parsad S,Knoebel RW,Pisano J,Pettit NN .2017 .Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia. J Oncol Pharm Pract, 23 : 575-581.
Wrenn RH,Cluck D,Kennedy L,Ohl C,Williamson JC3 C .2018 .Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia. J Oncol Pharm Pract, 24 : 170-5.
Horita N,Shibata Y,Watanabe H,Namkoong H,Kaneko T. .2017 .Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis. Clin Microbiol Infect, 23 : 723-9.
0

Citations

0

Downloads

68

Views